Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Thiopurine S-methyltransferase pharmacogenetics: functional characterization of a novel rapidly degraded variant allozyme.

Feng Q, Vannaprasaht S, Peng Y, Angsuthum S, Avihingsanon Y, Yee VC, Tassaneeyakul W, Weinshilboum RM.

Biochem Pharmacol. 2010 Apr 1;79(7):1053-61. doi: 10.1016/j.bcp.2009.11.016. Epub 2009 Nov 27.

2.

Thiopurine S-methyltransferase pharmacogenetics: chaperone protein association and allozyme degradation.

Wang L, Sullivan W, Toft D, Weinshilboum R.

Pharmacogenetics. 2003 Sep;13(9):555-64.

PMID:
12972954
3.

Thiopurine S-methyltransferase pharmacogenetics: variant allele functional and comparative genomics.

Salavaggione OE, Wang L, Wiepert M, Yee VC, Weinshilboum RM.

Pharmacogenet Genomics. 2005 Nov;15(11):801-15.

PMID:
16220112
4.

Thiopurine S-methyltransferase pharmacogenetics: autophagy as a mechanism for variant allozyme degradation.

Li F, Wang L, Burgess RJ, Weinshilboum RM.

Pharmacogenet Genomics. 2008 Dec;18(12):1083-94. doi: 10.1097/FPC.0b013e328313e03f.

5.

Human thiopurine S-methyltransferase pharmacogenetics: variant allozyme misfolding and aggresome formation.

Wang L, Nguyen TV, McLaughlin RW, Sikkink LA, Ramirez-Alvarado M, Weinshilboum RM.

Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9394-9. Epub 2005 Jun 20.

6.
7.

Canine red blood cell thiopurine S-methyltransferase: companion animal pharmacogenetics.

Salavaggione OE, Kidd L, Prondzinski JL, Szumlanski CL, Pankratz VS, Wang L, Trepanier L, Weinshilboum RM.

Pharmacogenetics. 2002 Dec;12(9):713-24.

PMID:
12464800
8.

Aggresome formation and pharmacogenetics: sulfotransferase 1A3 as a model system.

Wang L, Yee VC, Weinshilboum RM.

Biochem Biophys Res Commun. 2004 Dec 10;325(2):426-33.

PMID:
15530410
9.

Functional characterization of 23 allelic variants of thiopurine S-methyltransferase gene (TPMT*2 - *24).

Ujiie S, Sasaki T, Mizugaki M, Ishikawa M, Hiratsuka M.

Pharmacogenet Genomics. 2008 Oct;18(10):887-93. doi: 10.1097/FPC.0b013e3283097328.

PMID:
18708949
10.

Cat red blood cell thiopurine S-methyltransferase: companion animal pharmacogenetics.

Salavaggione OE, Yang C, Kidd LB, Thomae BA, Pankratz VS, Trepanier LA, Weinshilboum RM.

J Pharmacol Exp Ther. 2004 Feb;308(2):617-26. Epub 2003 Nov 10.

11.

Natriuretic peptide pharmacogenetics: membrane metallo-endopeptidase (MME): common gene sequence variation, functional characterization and degradation.

Pereira NL, Aksoy P, Moon I, Peng Y, Redfield MM, Burnett JC Jr, Wieben ED, Yee VC, Weinshilboum RM.

J Mol Cell Cardiol. 2010 Nov;49(5):864-74. doi: 10.1016/j.yjmcc.2010.07.020. Epub 2010 Aug 6.

12.

Human thiopurine methyltransferase pharmacogenetics: gene sequence polymorphisms.

Otterness D, Szumlanski C, Lennard L, Klemetsdal B, Aarbakke J, Park-Hah JO, Iven H, Schmiegelow K, Branum E, O'Brien J, Weinshilboum R.

Clin Pharmacol Ther. 1997 Jul;62(1):60-73.

PMID:
9246020
13.
14.

Four human thiopurine s-methyltransferase alleles severely affect protein structure and dynamics.

Rutherford K, Daggett V.

J Mol Biol. 2008 Jun 13;379(4):803-14. doi: 10.1016/j.jmb.2008.04.032. Epub 2008 Apr 18.

15.

Thiopurine methyltransferase pharmacogenetics: human gene cloning and characterization of a common polymorphism.

Szumlanski C, Otterness D, Her C, Lee D, Brandriff B, Kelsell D, Spurr N, Lennard L, Wieben E, Weinshilboum R.

DNA Cell Biol. 1996 Jan;15(1):17-30.

PMID:
8561894
16.

Identification and functional analysis of two rare allelic variants of the thiopurine S-methyltransferase gene, TPMT*16 and TPMT*19.

Hamdan-Khalil R, Gala JL, Allorge D, Lo-Guidice JM, Horsmans Y, Houdret N, Broly F.

Biochem Pharmacol. 2005 Feb 1;69(3):525-9. Epub 2004 Dec 10.

PMID:
15652243
17.

Human thiopurine methyltransferase: molecular cloning and expression of T84 colon carcinoma cell cDNA.

Honchel R, Aksoy IA, Szumlanski C, Wood TC, Otterness DM, Wieben ED, Weinshilboum RM.

Mol Pharmacol. 1993 Jun;43(6):878-87.

PMID:
8316220
18.
19.

Prospects and limits of pharmacogenetics: the thiopurine methyl transferase (TPMT) experience.

van Aken J, Schmedders M, Feuerstein G, Kollek R.

Am J Pharmacogenomics. 2003;3(3):149-55. Review.

PMID:
12814323
20.

Human liver thiopurine methyltransferase pharmacogenetics: biochemical properties, liver-erythrocyte correlation and presence of isozymes.

Szumlanski CL, Honchel R, Scott MC, Weinshilboum RM.

Pharmacogenetics. 1992 Aug;2(4):148-59.

PMID:
1306116

Supplemental Content

Support Center